CFAR is a repository of HIV/AIDS reagents, established in 1989 through Medical Research Council (MRC) funding.
It is one of only two in the world – and the only one in Europe – with the primary role of providing a wide range of basic and specialised research reagents for HIV/AIDS research.
We strive to identify and acquire new state-of-the-art materials for the benefit of the HIV research community.
We also provide large single batches of unique HIV/AIDS reagents for collaborative experiments as well as a safe banking facility for valuable research materials.
The complicated but necessary rules around transporting them safely between laboratories – especially internationally – is a real challenge for scientists distributing and acquiring HIV-related materials. CFAR provides a safe and efficient service for storing and distributing reagents and is certified under the ISO9001 Quality System.
CFAR is a central hub for scientists to deposit the reagents they develop – enabling simple dissemination of the reagents to researchers worldwide – and gives them the opportunity to obtain novel reagents for their own research.
We are here to:
CFAR currently houses over 6,000 reagents including:
We have a collaborative agreement with the AIDS Research and Reference Reagent Program funded by the National Institute of Health in the USA (NIH ARRRP) to share reagents.
CFAR is a designated World Health Organisation and the United Nations Joint Programme on HIV/AIDS Virus Network (WHO-UNAIDS) collaborating centre and houses the specimen collection of field HIV isolates from the 1990s.
NIBSC and CFAR are currently coordinating the EC Framework Programme VII infrastructures project EURIPRED.
Its aim is to improve networks between existing biobanks focusing on the poverty-related diseases of tuberculosis, malaria, HIV and hepatitis B/C.
EURIPRED is working towards reinforcing knowledge across the disease areas and facilitating the development of new tools (vaccines, drugs, microbicides) to combat tuberculosis, HIV, malaria, hepatitis B and hepatitis C. CFAR’s aim is to establish a repository for these diseases which both complements and mirrors that which is available for HIV.
For more information see the project’s website.
Sarah Gilbert - CFAR Project ManagerYann Le Duff – Postdoctoral ScientistMatthew Hurley – ScientistDiane Lomas – Scientist